WS #15827
Johnson & Johnson has raised its 2026 sales outlook to 6.7%-7.1%, projecting a $100.7 billion revenue midpoint, driven by strong pharmaceutical performance. In a contrasting move, GameStop shares hit a 52-week high as CEO Ryan Cohen continued his aggressive share buyback program, increasing his stake to over 42.4 million shares. These developments highlight divergent corporate strategies, with J&J focusing on organic growth guidance and GameStop leveraging insider confidence to stabilize its stock price.
Corporate Earnings and Insider Activity
Johnson & Johnson has raised its 2026 sales outlook to 6.7%-7.1%, projecting a $100.7 billion revenue midpoint, driven by strong pharmaceutical performance. In a contrasting move, GameStop shares hit a 52-week high as CEO Ryan Cohen continued his aggressive share buyback program, increasing his stake to over 42.4 million shares. These developments highlight divergent corporate strategies, with J&J focusing on organic growth guidance and GameStop leveraging insider confidence to stabilize its stock price.